Trend scenario PHF- 2018 identifies societal challenges for the future If historical trends continue unchanged, dementia will be the leading cause of disease burden in 2040 and the main cause of death.
Antimicrobial resistance is stable, but alertness remains necessary The number of bacteria strains resistant to antibiotics in humans has remained stable in the Netherlands over the past year.
Nanotechnology in the fight against cancer Nanotechnology offers improved options for the diagnosis and treatment of cancer.
Tracking down sources of disease outbreaks like Sherlock Holmes. 'I want to know the story behind an epidemic'. Interview with Jaap van Dissel, Director of RIVM Centre for Infectious Disease Control.
Cervical cancer screening in the Netherlands January 19 - 25 European Cervical Cancer Prevention Week.
State of infectious diseases in The Netherlands RIVM report 'State of Infectious Diseases 2012' provides insight into the development of infectious diseases in The Netherlands.
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.
Human and veterinary health sectors join forces for responsible use of antibiotics. Bacteria that are resistant to almost all antibiotics continue to spread across Europe. This was revealed by new figures from the European Centre for Disease Prevention and Control (ECDC).